Blackstone Inc’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-30,000
Closed -$2.96M 296
2021
Q4
$2.96M Hold
30,000
0.01% 263
2021
Q3
$2.98M Hold
30,000
0.01% 303
2021
Q2
$2.98M Buy
+30,000
New +$2.99M 0.01% 306

Other funds holding SNTI

Blackstone Inc's SNTI Position: Q1 2022 in Review

Blackstone Inc sold out of Senti Biosciences Holdings (SNTI) in Q1 2022, closing a stake of 30,000 shares — an estimated $2.96M sold.

Blackstone Inc first reported a position in SNTI in Q2 2021 and held it in 3 quarters. The position peaked at $2.98M in Q3 2021. 45 funds tracked by Wall St. Rank hold SNTI as of Q1 2022.

  • Blackstone Inc reported no remaining Senti Biosciences Holdings position as of Q1 2022 after selling out during the quarter.
  • Blackstone Inc sold 30,000 Senti Biosciences Holdings shares in Q1 2022, an estimated $2.96M.
  • Blackstone Inc first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 3 quarters.
  • Blackstone Inc's Senti Biosciences Holdings position peaked at $2.98M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2022.

Based on Blackstone Inc's 13F filing for Q1 2022, filed 16 May 2022.